Table of Contents
How is the risk appetite of investors evolving? Why do so many clinical trials contain major design errors? And how can the US respond to the Chinese biotech market?
Treehill Partners is an international strategic and financial advisory firm focused exclusively on healthcare.
At JPM 2026, Treehill ran a series of closed-door roundtables exploring the most pertinent topics in biotech and pharma.
Onyx sat down with CEO Ali Pashazadeh to find out more.
I hope you enjoy watching!
Yours sincerely,
Dr. Adil Ali
Comments